US 11690918
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted A61KA61K2039/505A61K31/551
Quick answer
US patent 11690918 (Pyrrolobenzodiazepine-anti-CD22 antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADC THERAPEUTICS SA
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K31/551, A61K31/5517, A61K39/001113